Johnson & Johnson stops mid-stage trial of drug for dengue prevention
Johnson & Johnson has discontinued its mid-stage trial, evaluating an antiviral drug, mosnodenvir, for the prevention of dengue.
Drugs
Health
Pharma
Drugs
Health
Pharma
WHO prequalifies Japan-based Takeda’s dengue vaccine for children
HQ Team May 15, 2024: The World Health Organization has prequalified a dengue vaccine for children made by Japan’s Takeda Pharmaceutical Company —.